<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://usa.alphagenics.co/blog/certificacion-issca-peptidos-medicos/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-12</news:publication_date><news:title>ISSCA Peptide Certification: What Physicians Learn</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/issca-celulas-madre-a-peptidos-medicina-regenerativa/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-12</news:publication_date><news:title>ISSCA: From Stem Cells to Peptides in Regenerative Medicine</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/issca-marco-clinico-peptidos-laboratorios-seguimiento/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-12</news:publication_date><news:title>ISSCA Peptide Clinical Framework: Labs and Follow-Up</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/glp-1-ra-agonistas-receptor-glp1-que-son/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-11</news:publication_date><news:title>GLP-1 RA: What GLP-1 Receptor Agonists Are</news:title></news:news></url><url><loc>https://usa.alphagenics.co/blog/rare-glp1r-variants-semaglutide-tirzepatide-helix-ashg-2026/</loc><news:news><news:publication><news:name>Alphagenics USA</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-11</news:publication_date><news:title>Rare GLP1R Variants Blunt Semaglutide, Not Tirzepatide: ASHG Data</news:title></news:news></url></urlset>
